Clinical Trial Update: A Study Evaluating the Immunotherapy Treatment for Ovarian Cancer and Other Advanced Malignancies. [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 1/2 immunotherapy study for ovarian cancer and other advanced malignant solid tumors, sponsored by the University o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Immunotherapy treatment

Snippet

Sponsor: University of Chicago | Conditions: Ovarian Cancer, Advanced Malignant Solid Tumor | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING